Waters Company Profile (NYSE:WAT)

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters Co. (NYSE:WAT) issued its earnings results on Tuesday, April, 25th. The company reported $1.46 earnings per share for the quarter, beating analysts' consensus estimates of $1.33 by $0.13. The company had revenue of $497.97 million for the quarter, compared to the consensus estimate of $489.37 million. Waters had a return on equity of 24.47% and a net margin of 24.06%. The firm's quarterly revenue was up 4.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.26 EPS. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Monday, July, 24th 2017. View Earnings Estimates for Waters.

Waters updated its second quarter earnings guidance on Tuesday, April, 25th. The company provided earnings per share guidance of $1.65-1.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.67. Waters also updated its FY17 guidance to $7.20-7.40 EPS.

11 analysts have issued 12-month price objectives for Waters' shares. Their forecasts range from $145.00 to $200.00. On average, they anticipate Waters' share price to reach $168.00 in the next twelve months. View Analyst Ratings for Waters.

Here are some recent quotes from research analysts about Waters stock:

• 1. Cantor Fitzgerald analysts commented, "1Q17 Results Summary. WAT reported 1Q17 total revenues of $498.0M (up 5% y/y and up 6% constant-currency basis), $9.6M above our estimate of $488.4M and $9.2M above FactSet consensus of $488.8M. Adjusted cash EPS of $1.46 was $0.13 above both our estimate and consensus of $1.33. Importantly, excluding a $0.09 benefit due to a new stock-based compensation accounting rule, 1Q17 adjusted EPS still beat our estimate and consensus by $0.04." (4/25/2017)
• 2. According to Zacks Investment Research, "Waters Corp. has managed to beat earnings estimates each time over the trailing four quarters. Further, over the past one year, shares of Waters Corp. have outperformed the Zacks Classified Instruments-Scientific industry’s average return. The company is enjoying robust momentum across pharmaceutical end markets and striking growth in recurring-revenue products. Going forward, the company believes that strength in end markets, stable demand from pharmaceutical business, growth in recurring revenue and balanced growth rates from other end-markets will accelerate its growth momentum. Waters Corp.’s strong market traction in emerging markets like China and India, add to its strength. However, escalating debt levels and related servicing costs could pressure margins, going forward. Currency headwinds are also expected to hinder the company’s sales in the coming quarters." (4/24/2017)
• 3. Jefferies Group LLC analysts commented, "WAT's analyst day was a platform for new leadership to offer a granular deepdive into future growth pillars (pharma, materials, food), reaffirm its strategic priorities & outline 3-yr financial goals'none of which deviated from the formula that has served it well over the past 10+ yrs. We came away more positive on the duration of its growth drivers (pharma), but less convinced of its leverage to further improve its industry-leading profit margins & ROIC." (3/3/2017)

Some companies that are related to Waters include C R Bard (BCR), Mettler-Toledo International (MTD), DENTSPLY SIRONA (XRAY), Cooper Companies (COO), Teleflex Incorporated (TFX), West Pharmaceutical Services (WST), Hill-Rom Holdings (HRC), Integra Lifesciences Holdings Corp (IART), ProShares UltraShort DJ-UBS Commodity (CMD), ICU Medical, Incorporated (ICUI), Insulet (PODD), Haemonetics (HAE), Inogen (INGN), Merit Medical Systems (MMSI), Halyard Health (HYH), Glaukos Corp (GKOS), Mazor Robotics Ltd - (MZOR) and Luminex (LMNX).

Waters' management team includes the folowing people:

• Douglas A. Berthiaume, Chairman of the Board
• Christopher J. O'Connell, President, Chief Executive Officer, Director
• Sherry L. Buck, Chief Financial Officer, Senior Vice President
• Mark T. Beaudouin, Senior Vice President, General Counsel, Secretary
• Elizabeth B. Rae, Senior Vice President - Global Human Resources
• Michael C. Harrington, Senior Vice President - Global Markets
• Terrance P. Kelly, Senior Vice President and President - TA Instruments
• Rohit Khanna, Senior Vice President - Applied Technology
• Ian S. King, Senior Vice President - Instrument Technology
• David A. Terricciano, Senior Vice President - Global Operations

Waters' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (9.37%), Massachusetts Financial Services Co. MA (9.18%), BlackRock Inc. (6.68%), State Street Corp (4.31%), Fundsmith LLP (4.29%) and Baillie Gifford & Co. (3.74%). Company insiders that own Waters stock include Arthur G Caputo, Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly and William J Miller. View Institutional Ownership Trends for Waters.

Waters' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Massachusetts Financial Services Co. MA, Bank of America Corp DE, Credit Agricole S A, Bank of New York Mellon Corp, Morgan Stanley, Russell Investments Group Ltd. and Acadian Asset Management LLC. Company insiders that have sold Waters stock in the last year include Arthur G Caputo, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna and Terrence P Kelly. View Insider Buying and Selling for Waters.

Waters' stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Mondrian Investment Partners LTD, Janus Capital Management LLC, Fundsmith LLP, Vanguard Group Inc., Marathon Asset Management LLP, Mawer Investment Management Ltd. and MARSHALL WACE ASIA Ltd. View Insider Buying and Selling for Waters.

Shares of Waters can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Waters stock can currently be purchased for approximately $178.07.